[1]
Yang, W. et al. 2025. Impact of PCSK9 Inhibitors on Bone Disease: A Comprehensive Drug-target Mendelian Randomization Study. Journal of Contemporary Medical Practice. 7, 5 (May 2025), 54–63. DOI:https://doi.org/10.53469/jcmp.2025.07(05).12.